Pages that link to "Q42446888"
Jump to navigation
Jump to search
The following pages link to Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission (Q42446888):
Displaying 35 items.
- Ion channels as drug targets in central nervous system disorders (Q27004533) (← links)
- Major channels involved in neuropsychiatric disorders and therapeutic perspectives (Q28290639) (← links)
- From pan-reactive KV7 channel opener to subtype selective opener/inhibitor by addition of a methyl group (Q28539924) (← links)
- Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing (Q30457731) (← links)
- Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats (Q34236634) (← links)
- Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration (Q34390785) (← links)
- HCN Channel Targets for Novel Antidepressant Treatment. (Q34557298) (← links)
- AMIGO-Kv2.1 Potassium Channel Complex Is Associated With Schizophrenia-Related Phenotypes (Q36377899) (← links)
- A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors (Q36675803) (← links)
- KCNQ channel openers reverse depressive symptoms via an active resilience mechanism. (Q36959869) (← links)
- From drugs to deprivation: a Bayesian framework for understanding models of psychosis (Q37370306) (← links)
- Voltage-gated potassium channels as therapeutic targets (Q37464784) (← links)
- Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy (Q37781356) (← links)
- Pharmacotherapy of epilepsy: newly approved and developmental agents (Q37831297) (← links)
- Abnormalities in thalamic neurophysiology in schizophrenia: Could psychosis be a result of potassium channel dysfunction? (Q37964414) (← links)
- Explaining Delusions: Reducing Uncertainty Through Basic and Computational Neuroscience (Q38759965) (← links)
- δ Subunit-containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine. (Q38849244) (← links)
- Addiction-related effects of DOV 216,303 and cocaine: A comparative study in the mouse. (Q39299851) (← links)
- The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo (Q39632547) (← links)
- Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model (Q39773112) (← links)
- M-type channels selectively control bursting in rat dopaminergic neurons (Q40266762) (← links)
- Inhibition of SK and M channel-mediated currents by 5-HT enables parallel processing by bursts and isolated spikes (Q40782618) (← links)
- Kv7 channels in the nucleus accumbens are altered by chronic drinking and are targets for reducing alcohol consumption (Q40806344) (← links)
- The anticonvulsant retigabine is a subtype selective modulator of GABAA receptors. (Q42212418) (← links)
- Downregulation of KCNQ4 by Janus kinase 2. (Q45817343) (← links)
- A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission (Q47569419) (← links)
- A pharmaco-EEG study of the interaction between ethanol and retigabine in rabbits. (Q48335756) (← links)
- KCNQ2/3 channel agonist flupirtine reduces cocaine place preference in rats (Q50459046) (← links)
- In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia (Q50684220) (← links)
- Kv7 (KCNQ) channel openers induce hypothermia in the mouse (Q51532244) (← links)
- Identification and validation of midbrain Kcnq4 regulation of heavy alcohol consumption in rodents. (Q54220815) (← links)
- The Kv7 potassium channel activator retigabine decreases alcohol consumption in rats (Q58258271) (← links)
- The Emerging Potential of Pharmacogenetics in Psychiatry (Q84515453) (← links)
- Heterozygous loss of epilepsy gene KCNQ2 alters social, repetitive and exploratory behaviors (Q91710465) (← links)
- Pharmacological Manipulation of K v 7 Channels as a New Therapeutic Tool for Multiple Brain Disorders (Q97420402) (← links)